Dr Reddy's Laboratories share price was trading lower by a percent intraday on October 22 after data breach forces the pharma company to shut plants.
In a major data breach, drug maker Dr Reddy's Laboratories has temporarily shutdown production across its key plants. The incident happened in the early hours.
Sources within the company confirmed to Moneycontrol about the breach, and the halt of production.
This comes just days after the company received an approval from DCGI to conduct phase 2 and 3 trials for a reworked protocol of a COVID-19 vaccine that sought some additional information.